![Jennifer Buell: NCI Announces Availability of Botensilimab for Clinical Development](https://oncodaily.com/pub/uploads/2024/07/IMG_0136.jpeg)
Jul 8, 2024, 12:29
Jennifer Buell: NCI Announces Availability of Botensilimab for Clinical Development
Jennifer Buell, President and Chief Executive Officer of MiNK Therapeutics, shared on X:
“NCI Announces Availability of Botensilimab for Clinical Development
Botensilimab is available through the NCI CTEP program in collaboration with Agenus. Strong LOIs for clinical studies are being evaluated.”
Read further.
Source: Jennifer Buell/X
Aug 29, 2024, 17:06